Previous 10 | Next 10 |
ENGLEWOOD, Colo. , July 11, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a development stage biopharmaceutical company focused on the discovery and development of a novel therapy aimed at treating common inflammatory conditions for which there are limited t...
ENGLEWOOD, Colo. , July 10, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a development stage biopharmaceutical company focused on the discovery and development of a novel therapy aimed at treating common inflammatory conditions for which there are limited t...
ENGLEWOOD, Colo. , June 19, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) ("Ampio"), today announced that it closed its previously announced public offering. Ampio issued 30,000,000 shares of common stock at an offering price of $0.40 per common share...
Ampio Pharmaceuticals (NYSEMKT: AMPE ) has entered into purchase agreements for the purchase of 25,320,000 common shares at $0.40 per share, for gross proceeds of $10.1M. More news on: Ampio Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...
ENGLEWOOD, Colo. , June 17, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) today announced today that it will offer up to $12 Million of its common stock in public offering. Ampio has entered into purchase agreements for the purchase of an aggrega...
Ampio Pharmaceuticals (NYSEMKT: AMPE ) sinks 22% in after-hours trading after announcing plans for a common stock offering . More news on: Ampio Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...
ENGLEWOOD, Colo. , June 14, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) ("Ampio"), today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Ampio expects to grant the underwriters a 45-day option to pu...
Ampio Pharmaceuticals (NYSEMKT: AMPE ) announces that it landed FDA approval of its special protocol assessment of a clinical protocol. More news on: Ampio Pharmaceuticals, Inc., Healthcare stocks news, Read more ...
ENGLEWOOD, Colo. , June 14, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) announced today that it received FDA approval of the Company's special protocol assessment (SPA) of a clinical protocol titled "A Randomized, Controlled, Double-Blind Study to Evaluate the ...
Introduction Every year the Russell Indexes are rebalanced to bring in new stocks and remove underperforming stocks. The FTSE Russell calls this event the annual reconstitution process, and it begins with evaluations in May and moves to the selection process on June 7th with the newly recons...
News, Short Squeeze, Breakout and More Instantly...
Ampio Pharmaceuticals Inc. Company Name:
AMPE Stock Symbol:
OTCMKTS Market:
Ampio Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Next.e.GO N.V. (EGOX) rose 94.4% to $0.07 on volume of 92,836,985 shares AGBA Group Holding Limited (AGBA) rose 46.1% to $1.505 on volume of 55,502,222 shares PROSHARES TRUST (SQQQ) rose 1.2% to $12.2099 on volume of 25,933,897 shares...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 7.2% to $0.04 on volume of 426,309,096 shares PROSHARES TRUST (SQQQ) rose 1.8% to $12.07 on volume of 171,048,374 shares AGBA Group Holding Limited (AGBA) rose 157.5% to $1.03 on volume of 121,894,6...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 73.2% to $0.0646 on volume of 191,555,690 shares AGBA Group Holding Limited (AGBA) rose 245.0% to $1.38 on volume of 41,065,125 shares TIAN RUIXIANG Holdings Ltd (TIRX) rose 135.2% to $1.14 on volum...